US5200197A
(en)
*
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
*
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5273760A
(en)
*
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5286493A
(en)
*
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5662933A
(en)
*
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6726930B1
(en)
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US5554379A
(en)
*
|
1994-06-20 |
1996-09-10 |
Kv Pharmaceutical Company |
Long acting GI and esophageal protectant
|
US5670163A
(en)
*
|
1994-06-20 |
1997-09-23 |
Kv Pharmaceuticals Company |
Long acting GI and esophageal protectant
|
US5554380A
(en)
*
|
1994-08-04 |
1996-09-10 |
Kv Pharmaceutical Company |
Bioadhesive pharmaceutical delivery system
|
US5658474A
(en)
*
|
1994-12-16 |
1997-08-19 |
Alza Corporation |
Method and apparatus for forming dispenser delivery ports
|
US6471994B1
(en)
*
|
1995-01-09 |
2002-10-29 |
Edward Mendell Co., Inc. |
Pharmaceutical excipient having improved compressibility
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
IL116674A
(en)
*
|
1995-01-09 |
2003-05-29 |
Mendell Co Inc Edward |
Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
|
US5948438A
(en)
*
|
1995-01-09 |
1999-09-07 |
Edward Mendell Co., Inc. |
Pharmaceutical formulations having improved disintegration and/or absorptivity
|
US6395303B1
(en)
*
|
1996-06-10 |
2002-05-28 |
Edward Mendell Co., Inc. |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
|
US6936277B2
(en)
*
|
1995-01-09 |
2005-08-30 |
J. Rettenmaier & Soehne Gmbh & Co. Kg |
Pharmaceutical excipient having improved compressibility
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
AU695734B2
(en)
|
1996-07-08 |
1998-08-20 |
Penwest Pharmaceuticals Co. |
Sustained release matrix for high-dose insoluble drugs
|
AU8293498A
(en)
|
1997-07-02 |
1999-01-25 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
US6056977A
(en)
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
AU5644400A
(en)
*
|
1999-09-24 |
2001-03-29 |
Rohm And Haas Company |
Pellet compositions
|
ATE391495T1
(de)
|
1999-09-30 |
2008-04-15 |
Penwest Pharmaceuticals Co |
Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
|
EP2295043A1
(de)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
GB0025208D0
(en)
*
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
KR101167465B1
(ko)
|
2000-10-30 |
2012-07-27 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
WO2003070225A1
(en)
*
|
2002-02-21 |
2003-08-28 |
Amarin Development Ab |
A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
EP1499291B1
(de)
*
|
2002-04-29 |
2009-01-07 |
ALZA Corporation |
Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
|
MXPA04012021A
(es)
*
|
2002-05-31 |
2005-08-16 |
Johnson & Johnson |
Formas de dosis y composiciones para la administracion osmotica de dosis variables de oxicodona.
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
HUE026034T2
(en)
|
2002-12-13 |
2016-05-30 |
Durect Corp |
Oral delivery system containing an oral high-viscosity carrier
|
JP2006522016A
(ja)
*
|
2003-01-14 |
2006-09-28 |
アルザ・コーポレーシヨン |
改変された粘度の層を用いる方法および投薬形態物
|
WO2004071497A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
CA2534920A1
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
CA2536507A1
(en)
*
|
2003-08-22 |
2005-03-10 |
Alza Corporation |
Stepwise delivery of topiramate over prolonged period of time
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
MXPA06003452A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
NZ546148A
(en)
*
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
BRPI0414802A
(pt)
*
|
2003-09-26 |
2006-11-14 |
Alza Corp |
formas de dosagem osmóticas para liberação controlada de alprazolam
|
EP1663145B1
(de)
*
|
2003-09-26 |
2011-04-06 |
ALZA Corporation |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
AU2004285533A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption
|
EP1703894A1
(de)
*
|
2003-12-23 |
2006-09-27 |
ALZA Corporation |
Verfahren und dosierformen zur erhöhung der löslichkeit von arzneizusammensetzungen für kontrollierte abgabe
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
AU2004312082A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms
|
JP2007517063A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
トピラメートの新規な薬剤組成物および剤形
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
ATE413864T1
(de)
*
|
2005-01-27 |
2008-11-15 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
CA2605180A1
(en)
*
|
2005-04-19 |
2006-10-26 |
Alza Corporation |
Controlled delivery dosage form of tramadol and gabapentin
|
DE102005024614A1
(de)
*
|
2005-05-25 |
2006-11-30 |
Röhm Gmbh |
Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
|
JP2009500339A
(ja)
*
|
2005-06-29 |
2009-01-08 |
アルザ・コーポレーシヨン |
浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
|
EP1912622A2
(de)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotische dosierungsformen mit halbdurchlässigen membranen mit polymer-mischungen mit verbesserten eigenschaften
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
WO2008011596A2
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophilic abuse deterrent delivery system
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
JPWO2008084698A1
(ja)
*
|
2006-12-28 |
2010-04-30 |
アステラス製薬株式会社 |
タクロリムス徐放性医薬組成物
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
WO2010132204A1
(en)
|
2009-05-12 |
2010-11-18 |
Bpsi Holdings, Llc. |
Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
|
EP2437733A4
(de)
*
|
2009-06-02 |
2014-01-08 |
Dow Global Technologies Llc |
Retard-darreichungsform
|
WO2011043370A1
(ja)
*
|
2009-10-09 |
2011-04-14 |
旭化成ケミカルズ株式会社 |
コーティングフィルム、及びそれを用いた顆粒、錠剤
|
EP2554168B1
(de)
|
2010-03-29 |
2018-01-24 |
Astellas Pharma Inc. |
Pharmazeutische zusammensetzung mit kontrollierter freisetzung
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
RU2020129191A
(ru)
|
2018-02-16 |
2022-03-16 |
Эсперион Терапеутикс, Инк. |
Композиции с замедленным высвобождением бемпедоевой кислоты
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|